aridispharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-Agent: * | ||
Meta Tags
| Title | Aridis Pharmaceuticals | Innovative Therapies for Antibiotic Resistant |
| Description | About Company Company Overview Board of Directors Executive Team Advisory Board Pipeline Product Overview AR-301 (Tosatoxumab) AR-320 (Suvratoxumab) AR-501 (Pan |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 192.124.249.68 |
| Location | - |
Related Websites
| Site | Rank |
More to Explore
aridispharma.com Valuation
|
US$13,124,546
Last updated: 2023-05-08 03:02:53
aridispharma.com has Semrush global rank of 806,451. aridispharma.com has an estimated worth of US$ 13,124,546, based on its estimated Ads revenue. aridispharma.com receives approximately 1,514,371 unique visitors each day. Its web server is located in -, with IP address 192.124.249.68. According to SiteAdvisor, aridispharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$13,124,546 |
| Daily Ads Revenue | US$12,115 |
| Monthly Ads Revenue | US$363,449 |
| Yearly Ads Revenue | US$4,361,388 |
| Daily Unique Visitors | 100,959 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| aridispharma.com. | A | 599 | IP: 192.124.249.68 |
| aridispharma.com. | NS | 3600 | NS Record: ns18.domaincontrol.com. |
| aridispharma.com. | NS | 3600 | NS Record: ns17.domaincontrol.com. |
| aridispharma.com. | MX | 3600 | MX Record: 5 ALT1.ASPMX.L.GOOGLE.com. |
| aridispharma.com. | MX | 3600 | MX Record: 5 ALT2.ASPMX.L.GOOGLE.com. |
| aridispharma.com. | MX | 3600 | MX Record: 10 ALT3.ASPMX.L.GOOGLE.com. |
| aridispharma.com. | MX | 3600 | MX Record: 10 ALT4.ASPMX.L.GOOGLE.com. |
| aridispharma.com. | MX | 3600 | MX Record: 1 ASPMX.L.GOOGLE.com. |
| aridispharma.com. | TXT | 3600 | TXT Record: v=spf1 include:_spf.google.com ~all |
| aridispharma.com. | TXT | 3600 | TXT Record: google-site-verification=OkY_fzNqV2QSh0KX1ZpxVx0HSrSHu5ysuSStJlRJA7c |
HtmlToTextCheckTime:2023-05-08 03:02:53
| Company Company Overview Board of Directors Executive Team Advisory Board Pipeline Product Overview AR-301 (Tosatoxumab) AR-320 (Suvratoxumab) AR-501 (Panaecin ™ ) AR-701 (COVID-19 mAb) Preclinical AR-401 Out-licensed Products AR-105 (Aerucin ® ) AR-101 (Aerumab TM ) AR-201 TECHNOLOGY Technology Overview ⅄PEX TM MabIgX ® Therapeutic Targets HAP / VAP VAP Prevention Cystic Fibrosis COVID-19 Disease Investors Welcome Corporate Governance Board of Directors Board Committees News Releases SEC Filings Stock Information Historical Stock Price Analyst Coverage Events and Webcasts Publications and Posters Investor Alerts Investor Inquiries Contact Us Contact Us Careers Company Company Overview Board of Directors Executive Team Advisory Board Pipeline Product Overview AR-301 (Tosatoxumab) AR-320 (Suvratoxumab) AR-501 (Panaecin ™ ) AR-701 (COVID-19 mAb) Preclinical AR-401 Out-licensed Products AR-105 (Aerucin ® ) AR-101 (Aerumab TM ) AR-201 TECHNOLOGY Technology Overview ⅄PEX TM MabIgX ® |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: Sucuri/Cloudproxy Date: Fri, 29 Oct 2021 05:41:23 GMT Content-Type: text/html; charset=UTF-8 Content-Length: 0 Connection: keep-alive X-Sucuri-ID: 20018 X-XSS-Protection: 1; mode=block X-Frame-Options: SAMEORIGIN X-Content-Type-Options: nosniff Age: 0 Content-Security-Policy: upgrade-insecure-requests Location: https://www.aridispharma.com/ Strict-Transport-Security: max-age=300 Vary: User-Agent X-Backend: local X-Cache: uncached X-Cache-Hit: MISS X-Cacheable: NO:HTTPS Redirect X-Content-Type-Options: nosniff X-Redirect-By: WordPress X-Xss-Protection: 1; mode=block X-Sucuri-Cache: MISS HTTP/2 200 server: nginx date: Fri, 29 Oct 2021 05:41:23 GMT content-type: text/html; charset=UTF-8 x-sucuri-id: 20018 x-xss-protection: 1; mode=block x-frame-options: SAMEORIGIN x-content-type-options: nosniff content-security-policy: upgrade-insecure-requests; accept-ranges: bytes age: 18222 content-security-policy: upgrade-insecure-requests strict-transport-security: max-age=300 vary: Accept-Encoding, User-Agent x-backend: local x-cache: cached x-cache-hit: HIT x-cacheable: YES:Forced x-content-type-options: nosniff x-xss-protection: 1; mode=block strict-transport-security: max-age=31536000; includeSubDomains x-sucuri-cache: MISS |
aridispharma.com Whois Information
Domain Name: ARIDISPHARMA.COM Registry Domain ID: 137273432_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2019-12-17T19:19:41Z Creation Date: 2004-12-12T23:00:58Z Registry Expiry Date: 2021-12-12T23:00:58Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS17.DOMAINCONTROL.COM Name Server: NS18.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T20:05:04Z <<< |